ERBB2 and breast cancer: Together, these data demonstrate that glutamine is a key metabolite for the growth of ERBB2/Neu-induced breast cancer cells, and that the PGC-1α-mediated increase in glutamine metabolism is associated with protection against low glucose conditions and hypoxia, two conditions that can favor glutamine metabolism.